In MIA PaCa-2 (a pancreatic cancer cell), LOX-PP attenuated the ERK and Akt activities and decreased the levels of the NF-Kβ p65 and RelB subunits and cyclin D1, which are activated by RAS signalling [56]. The gene discussed is AKT1; the disease is pancreatic neoplasm.